Decreased Serum Adiponectin Level during Catecholamine Crisis in an Obese Patient with Pheochromocytoma
Yukiyoshi Okauchi1, Chisaki Ishibashi1, Kunihiko Shu1
1Diabetes Center, Toyonaka Municipal Hospital, Japan.
Abstract:
We herein report the case of a 37-year-old man with both pheochromocytoma and visceral fat accumulation and describe the sequential changes in his adiponectin levels throughout the clinical course from catecholamine crisis until the follow-up for adrenalectomy. His adiponectin level decreased during catecholamine crisis and increased after adrenalectomy. However, his adiponectin level decreased again at two years postoperatively when his visceral fat area greatly increased. This case suggests that catecholamines and visceral fat volume may affect adiponectin metabolism in subjects with pheochromocytoma, which may precipitate cardiovascular complications in this endocrine disease.
Related Concept Videos
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Decreasing Function
Obesity
Decreased Body Temperature


